|
FBXL15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.756200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.721900E-02 |
| Normal-vs-Stage2 |
1.518020E-01 |
| Normal-vs-Stage3 |
4.026000E-04 |
| Normal-vs-Stage4 |
1.031540E-02 |
| Stage1-vs-Stage2 |
8.467800E-01 |
| Stage1-vs-Stage3 |
1.216990E-01 |
| Stage1-vs-Stage4 |
5.310800E-01 |
| Stage2-vs-Stage3 |
2.326600E-01 |
| Stage2-vs-Stage4 |
5.312000E-01 |
| Stage3-vs-Stage4 |
4.541600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.964500E-04 |
| Normal-vs-AfricanAmerican |
4.959400E-03 |
| Normal-vs-Asian |
1.516040E-01 |
| Caucasian-vs-AfricanAmerican |
5.33370000055378E-07 |
| Caucasian-vs-Asian |
9.203600E-01 |
| AfricanAmerican-vs-Asian |
3.810300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.613600E-04 |
| Normal-vs-Female |
2.216600E-01 |
| Male-vs-Female |
8.880100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.212200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.975380E-03 |
| Normal-vs-Age(61-80Yrs) |
1.641790E-02 |
| Normal-vs-Age(81-100Yrs) |
8.115400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.424600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.154600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.982770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.655000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.270950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.419050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.464000E-01 |
| Normal-vs-Grade 2 |
3.768300E-02 |
| Normal-vs-Grade 3 |
2.421700E-03 |
| Normal-vs-Grade 4 |
3.660700E-03 |
| Grade 1-vs-Grade 2 |
2.384800E-01 |
| Grade 1-vs-Grade 3 |
1.842200E-01 |
| Grade 1-vs-Grade 4 |
1.551830E-01 |
| Grade 2-vs-Grade 3 |
2.955800E-01 |
| Grade 2-vs-Grade 4 |
2.348600E-01 |
| Grade 3-vs-Grade 4 |
7.025800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.772780E-04 |
| Normal-vs-ccB subtype |
4.18129999513184E-08 |
| ccA subtype-vs-ccB subtype |
3.064200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.416600E-03 |
| Normal-vs-N1 |
1.243790E-01 |
| N0-vs-N1 |
9.086400E-01 |
|
|
